Latest filing published 14 Jan 2020 for Idera Pharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
No signal scores available.
Jonathan Michael Yingling: trading record in brief
All filings by Jonathan Michael Yingling on record concern Idera Pharmaceuticals, Inc. In total, 4 filings cover trades dated from 3 January 2019 to 10 January 2020.
Every open-market trade on record is a sale: 2 sales worth €5,538. Besides market trades, the filings include 2 share grants. Since January 2020: no purchases and 2 sales on the market.
The record was last updated on 14 January 2020 with a share grant in Idera Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan Michael Yingling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001179110-20-000567:0
- 1,742 shares@ US$1.78100.0% of flowCommon StockSEC:0001179110-20-000450:0
- 18,100 shares0Common StockSEC:0001179110-19-000536:0
3 of 3 declarations